L Tschopp

454 total citations
21 papers, 371 citations indexed

About

L Tschopp is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, L Tschopp has authored 21 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in L Tschopp's work include Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Treatment and Pharmacology (4 papers). L Tschopp is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Treatment and Pharmacology (4 papers). L Tschopp collaborates with scholars based in Switzerland, Italy and Germany. L Tschopp's co-authors include M. Fopp, F. Cavalli, Aloïs Gratwohl, P Maurice, V von Fliedner, Paul Imbach, F Cavalli, Willi Berchtold, Andreas Steck and Rudolf Häusler and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

L Tschopp

21 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Tschopp Switzerland 8 193 103 87 74 48 21 371
W. Jeffrey Baker United States 8 84 0.4× 64 0.6× 74 0.9× 66 0.9× 37 0.8× 12 319
Pierluigi Marradi Italy 12 103 0.5× 74 0.7× 91 1.0× 53 0.7× 69 1.4× 22 377
Patricia N. Konrad United States 12 175 0.9× 194 1.9× 36 0.4× 45 0.6× 25 0.5× 20 610
M. Nagel‐Hiemke Germany 9 144 0.7× 52 0.5× 52 0.6× 20 0.3× 11 0.2× 17 374
Yoshito Tsukada Japan 13 65 0.3× 90 0.9× 23 0.3× 21 0.3× 16 0.3× 28 323
Hidetaka Niizuma Japan 12 52 0.3× 136 1.3× 68 0.8× 23 0.3× 53 1.1× 34 368
J R Schriber United States 8 178 0.9× 28 0.3× 87 1.0× 29 0.4× 22 0.5× 9 321
Kálmán Rák Hungary 12 187 1.0× 73 0.7× 32 0.4× 15 0.2× 19 0.4× 39 346
C.C So China 13 272 1.4× 184 1.8× 85 1.0× 40 0.5× 13 0.3× 36 482
Yuichi Konuma Japan 9 176 0.9× 184 1.8× 142 1.6× 12 0.2× 21 0.4× 16 490

Countries citing papers authored by L Tschopp

Since Specialization
Citations

This map shows the geographic impact of L Tschopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Tschopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Tschopp more than expected).

Fields of papers citing papers by L Tschopp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Tschopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Tschopp. The network helps show where L Tschopp may publish in the future.

Co-authorship network of co-authors of L Tschopp

This figure shows the co-authorship network connecting the top 25 collaborators of L Tschopp. A scholar is included among the top collaborators of L Tschopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Tschopp. L Tschopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fopp, M., Martin F. Fey, M. Bacchi, et al.. (1997). Post-remission therapy of adult acute myeloid leukaemia: One cycle of high-dose versus standard-dose cytarabine. Annals of Oncology. 8(3). 251–257. 28 indexed citations
3.
Tschopp, L, et al.. (1989). [Autologous bone marrow transfusion in the treatment of adults with hematologic neoplasms. Experiences from Bern].. PubMed. 119(25). 902–10. 2 indexed citations
4.
Sauter, C., P. Alberto, Willi Berchtold, et al.. (1987). Long-Term Results of Two Swiss AML Studies. Hämatologie und Bluttransfusion. 30. 38–44. 6 indexed citations
5.
Tschopp, L, C. Sauter, P Maurice, et al.. (1986). Efficacy and clinical cross-resistance of a new combination therapy (AMSA/VP16) in previously treated patients with acute nonlymphocytic leukemia.. Journal of Clinical Oncology. 4(3). 318–324. 26 indexed citations
6.
Sessa, Cristiana, L Tschopp, M. Fopp, & F. Cavalli. (1985). Phase-I trial of 4-demethoxydaunorubicin in acute leukaemias. Investigational New Drugs. 3(4). 357–359. 4 indexed citations
7.
Fopp, M., Paul Imbach, L Tschopp, et al.. (1984). ACUTE MYELOGENOUS LEUKAEMIA: MAINTENANCE CHEMOTHERAPY AFTER EARLY CONSOLIDATION TREATMENT DOES NOT PROLONG SURVIVAL. The Lancet. 323(8373). 379–382. 97 indexed citations
8.
9.
Goldhirsch, Aron, et al.. (1982). [Prevention of cytostatic-related hair loss by hypothermia of a hairy scalp using a cooling cap].. PubMed. 112(16). 568–71. 5 indexed citations
10.
Brunner, Kurt, Aron Goldhirsch, R Joss, Roland Sonntag, & L Tschopp. (1981). [Results of, and indications for adjuvant chemotherapy in breast cancer].. PubMed. 111(23). 838–45. 1 indexed citations
11.
Goldhirsch, Aron, et al.. (1980). Case Report Acute erythroleukemia following chemotherapy for Hodgkin’s disease. The American Journal of the Medical Sciences. 280(1). 53–56. 7 indexed citations
12.
Goldhirsch, Aron, et al.. (1980). Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma.. PubMed. 64(2-3). 335–7. 1 indexed citations
13.
Cavalli, F, et al.. (1978). A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(12). 2125–6. 36 indexed citations
14.
Cavalli, F., et al.. (1978). Die Kombination von Adriamycin undcis-Diamino-dichloro-platin (II) in der Behandlung therapieresistenter, fortgeschrittener Ovarialkarzinome. DMW - Deutsche Medizinische Wochenschrift. 103(22). 927–931. 5 indexed citations
15.
Cavalli, Franco, et al.. (1977). [Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)].. PubMed. 107(52). 1960–6. 12 indexed citations
16.
Cavalli, F, et al.. (1977). Akute myeloische Leukämie im Krankheitsverlauf des Morbus Hodgkin. DMW - Deutsche Medizinische Wochenschrift. 102(28). 1019–1024. 7 indexed citations
17.
Cavalli, F., Henrik Hartmann, L Tschopp, C. Sauter, & P. Alberto. (1977). [Therapeutic results and prognostic factors in acute lymphatic leukemia in the adult].. PubMed. 107(39). 1361–6. 1 indexed citations
18.
Cavalli, F, et al.. (1977). [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].. PubMed. 107(26). 912–5. 1 indexed citations
19.
Cavalli, F, et al.. (1976). [First therapeutic experience with cis-platinum(II)diamindichloride (NSC 119875) in metastasizing ovarian and testicular carcinoma].. PubMed. 106(22). 754–7. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Jeffrey Baker Breakdown of academic impact, for papers by Pierluigi Marradi Breakdown of academic impact, for papers by Patricia N. Konrad Breakdown of academic impact, for papers by M. Nagel‐Hiemke Breakdown of academic impact, for papers by Yoshito Tsukada Breakdown of academic impact, for papers by Hidetaka Niizuma Breakdown of academic impact, for papers by J R Schriber Breakdown of academic impact, for papers by Kálmán Rák Breakdown of academic impact, for papers by C.C So Breakdown of academic impact, for papers by Yuichi Konuma
Rankless by CCL
2026